NEXAVAR Side Effects

7007222-4 | Burning Sensation, Dermatitis Bullous, Eyelid Oedema, Nasal Mucosal Disorder, Palmar-plantar Erythrodysaesthesia Syndrome, Rhinalgia
on Sep 09, 2010 Male patient from FRANCE , 74 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, dermatitis bullous, eyelid oedema, nasal mucosal disorder, palmar-plantar erythrodysaesthesia syndrome, rhinalgia. Nexavar dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), TAHOR (View Tahor Review and Tahor Label ), TRIVASTAL (View Trivastal Review and Trivastal Label ), MECIR (View Mecir Review and Mecir Label ).

7007219-4 | Anaemia, Blood Creatinine Increased, Blood Urea Increased, Renal Cell Carcinoma, Thrombocytosis
Patient was taking Nexavar (View Usage). Patient had the following side effects: anaemia, blood creatinine increased, blood urea increased, renal cell carcinoma, thrombocytosis on Sep 15, 2010 from CZECH REPUBLIC Additional patient health information: Male patient , 58 years of age, was diagnosed with renal cancer and. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with LOZAP (View Lozap Review and Lozap Label ), VIGANTOL (View Vigantol Review and Vigantol Label ), CALCIUM (View Calcium Review and Calcium Label ), MORPHINE (View Morphine Review and Morphine Label ), ZOMETA (View Zometa Review and Zometa Label ).

7007194-2 | Atrioventricular Block Complete, Torsade De Pointes
Adverse event was reported on Aug 16, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: ) was diagnosed with hepatic neoplasm malignant and. Location: FRANCE , 70 years of age, weighting 169.8 lb, After Nexavar was administered, patient had the following side effects: atrioventricular block complete, torsade de pointes. Patient was hospitalized.

7007193-0 | Dyspnoea, Fatigue, Weight Decreased
on Sep 02, 2010 Female patient from BELGIUM , weighting 114.6 lb, was diagnosed with thyroid cancer (What is thyroid cancer?), cancer pain, hypertension and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, fatigue, weight decreased. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with NULYTELY (2 Sachets Per Day) (View Nulytely Review and Nulytely Label ), DURAGESIC 100 (50 Mcg/2 Days.) (View Duragesic-100 Review and Duragesic-100 Label ), MS DIRECT (View Ms Direct Review and Ms Direct Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), ELTHYRONE (View Elthyrone Review and Elthyrone Label ), CORDARONE (View Cordarone Review and Cordarone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.


7005519-5 | Gangrene, Palmar-plantar Erythrodysaesthesia Syndrome
on Sep 07, 2010 Male patient from ITALY , 75 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient had the following side effects: gangrene, palmar-plantar erythrodysaesthesia syndrome. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg.

7004676-4 | Balance Disorder, Disorientation, Oedema Peripheral, Palmar-plantar Erythrodysaesthesia Syndrome, Pruritus, Pyrexia, Tremor, Urticaria
Patient was taking Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: balance disorder, disorientation, oedema peripheral, palmar-plantar erythrodysaesthesia syndrome, pruritus, pyrexia, tremor, urticaria on Jun 17, 2010 from FRANCE Additional patient health information: Female patient , 88 years of age, was diagnosed with hepatic neoplasm malignant, hypertension, osteoarthritis (What is osteoarthritis?), asthma (What is asthma?) and. Nexavar dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), IXPRIM (View Ixprim Review and Ixprim Label ), ACETAMINOPHEN W/ PROPOXYPHENE HCL (View Acetaminophen W/ Propoxyphene Hcl Review and Acetaminophen W/ Propoxyphene Hcl Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), BECOTIDE (View Becotide Review and Becotide Label ).

7004662-4 | C-reactive Protein Increased, Chest Discomfort, Decreased Appetite, Dementia, Dyspnoea, Eczema, Epistaxis, Malaise, Nausea
Adverse event was reported on Sep 13, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 82 years of age, weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, chest discomfort, decreased appetite, dementia (What is dementia?), dyspnoea, eczema (What is eczema?), epistaxis, malaise, nausea (What is nausea?). During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), AZELASTINE HCL (View Azelastine Hcl Review and Azelastine Hcl Label ), ITOROL (View Itorol Review and Itorol Label ), TANATRIL (View Tanatril Review and Tanatril Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ). Patient was hospitalized.

7004661-2 | Burning Sensation, Dermatitis Bullous, Eyelid Oedema, Nasal Mucosal Disorder, Palmar-plantar Erythrodysaesthesia Syndrome, Rhinalgia
on Sep 09, 2010 Male patient from FRANCE , 74 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient had the following side effects: burning sensation, dermatitis bullous, eyelid oedema, nasal mucosal disorder, palmar-plantar erythrodysaesthesia syndrome, rhinalgia. Nexavar dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), TAHOR (View Tahor Review and Tahor Label ), TRIVASTAL (View Trivastal Review and Trivastal Label ), MECIR (View Mecir Review and Mecir Label ).

7004660-0 | Disseminated Intravascular Coagulation, Renal Failure Acute
on Sep 15, 2010 Male patient from JAPAN , 56 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: disseminated intravascular coagulation, renal failure acute. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg.

7001729-1 | Ascites, Fall, Jaundice, Syncope
Patient was taking Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, fall (What is fall?), jaundice (What is jaundice?), syncope on Sep 14, 2010 from FRANCE Additional patient health information: Male patient , 62 years of age, was diagnosed with hepatic neoplasm malignant and. Nexavar dosage: . During the same period patient was treated with COLCHIMAX (View Colchimax Review and Colchimax Label ), STILNOX (View Stilnox Review and Stilnox Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), TRIATEC (View Triatec Review and Triatec Label ), ZYLORIC (View Zyloric Review and Zyloric Label ). Patient was hospitalized.

7001728-X | Ascites, Hepatic Function Abnormal
Adverse event was reported on Sep 10, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Total Daily Dose: 800 Mg) was diagnosed with hepatic neoplasm malignant and. Location: FRANCE , 71 years of age, Patient had the following side effects: ascites, hepatic function abnormal. Patient was hospitalized.

7001726-6 | Gangrene, Palmar-plantar Erythrodysaesthesia Syndrome
on Sep 07, 2010 Male patient from ITALY , 75 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: gangrene, palmar-plantar erythrodysaesthesia syndrome. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg.

6999089-5 | Neuropathy Peripheral, Palmar-plantar Erythrodysaesthesia Syndrome
on Sep 10, 2010 Male patient from UNITED STATES , 63 years of age, was diagnosed with thyroid cancer metastatic and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: neuropathy peripheral, palmar-plantar erythrodysaesthesia syndrome. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg.

6999083-4 | Liver Function Test Abnormal
Patient was taking Nexavar (View Usage). Patient had the following side effects: liver function test abnormal on Sep 13, 2010 from JAPAN Additional patient health information: Male patient , 64 years of age, weighting 127.9 lb, was diagnosed with hepatic neoplasm malignant, hepatitis b (What is hepatitis b?) and. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), BARACLUDE (View Baraclude Review and Baraclude Label ), HIRUDOID (View Hirudoid Review and Hirudoid Label ). Patient was hospitalized.

6999081-0 | Delirium
Adverse event was reported on Sep 13, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant, hypertension, gastric ulcer, hepatic cirrhosis, diabetes mellitus and. Location: JAPAN , 76 years of age, weighting 123.5 lb, After Nexavar was administered, patient had the following side effects: delirium. During the same period patient was treated with AMLODIPINE (Unit Dose: 5 Mg) (View Amlodipine Review and Amlodipine Label ), PARIET (Unit Dose: 10 Mg) (View Pariet Review and Pariet Label ), AMINOLEBAN EN (Unit Dose: 50 Mg) (View Aminoleban En Review and Aminoleban En Label ), LICKLE (Unit Dose: 4.74 G) (View Lickle Review and Lickle Label ), GLYCYRON (View Glycyron Review and Glycyron Label ), ALLOID G (Unit Dose: 2 %) (View Alloid G Review and Alloid G Label ), FASTIC (Unit Dose: 90 Mg) (View Fastic Review and Fastic Label ).

6999018-4 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Diarrhoea, Disseminated Intravascular Coagulation, Hyponatraemia, Metabolic Acidosis, Renal Disorder, Thrombocytopenia
on Sep 16, 2010 Female patient from JAPAN , 73 years of age, weighting 130.1 lb, was diagnosed with hepatic neoplasm malignant, hepatitis c (What is hepatitis c?) and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, diarrhoea, disseminated intravascular coagulation, hyponatraemia, metabolic acidosis, renal disorder, thrombocytopenia. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with NEO MINOPHAGEN C (View Neo-minophagen C Review and Neo-minophagen C Label ), NEO MINOPHAGEN C (View Neo-minophagen C Review and Neo-minophagen C Label ), NEO MINOPHAGEN C (View Neo-minophagen C Review and Neo-minophagen C Label ), NEO MINOPHAGEN C (View Neo-minophagen C Review and Neo-minophagen C Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

6999017-2 | Atrial Fibrillation, Deep Vein Thrombosis, Dyspnoea, Encephalopathy, Hyperkalaemia, Pulmonary Oedema, Renal Failure Acute, Somnolence
on Sep 14, 2010 Male patient from UNITED STATES , 71 years of age, was diagnosed with hepatic neoplasm malignant, anaemia, hepatic encephalopathy, gastric ulcer, hypertension, oedema and was treated with Nexavar (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), deep vein thrombosis (What is deep vein thrombosis?), dyspnoea, encephalopathy, hyperkalaemia, pulmonary oedema, renal failure acute, somnolence. Nexavar dosage: Total Daily Dose: 200 Mg Unit Dose: 200 Mg. During the same period patient was treated with PROCRIT (40,000 Weekly) (View Procrit Review and Procrit Label ), RIFAXIMIN (View Rifaximin Review and Rifaximin Label ), LACTULOSE (Total Daily Dose: 10 G) (View Lactulose Review and Lactulose Label ), PREVACID (Total Daily Dose: 30 Mg) (View Prevacid Review and Prevacid Label ), INDERAL LA (Total Daily Dose: 120 Mg) (View Inderal La Review and Inderal La Label ), TORSEMIDE (Total Daily Dose: 40 Mg) (View Torsemide Review and Torsemide Label ). Patient was hospitalized and became disabled.

6999015-9 | Hepatic Encephalopathy, Hepatic Neoplasm Malignant, Hypothyroidism
Patient was taking Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: hepatic encephalopathy, hepatic neoplasm malignant, hypothyroidism on Sep 14, 2010 from JAPAN Additional patient health information: Female patient , 73 years of age, weighting 77.16 lb, was diagnosed with hepatic neoplasm malignant and. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with BASEN OD (Unit Dose: 0.2 Mg) (View Basen Od Review and Basen Od Label ), URSO 250 (Unit Dose: 100 Mg) (View Urso 250 Review and Urso 250 Label ), GLAKAY (Unit Dose: 15 Mg) (View Glakay Review and Glakay Label ), TAKEPRON (Unit Dose: 30 Mg) (View Takepron Review and Takepron Label ), AMARYL (Unit Dose: 1 Mg) (View Amaryl Review and Amaryl Label ), ALDACTONE (Unit Dose: 25 Mg) (View Aldactone Review and Aldactone Label ), FERROMIA (Unit Dose: 50 Mg) (View Ferromia Review and Ferromia Label ), GLYPHAGEN (Unit Dose: 20 Ml) (View Glyphagen Review and Glyphagen Label ). Patient was hospitalized.

6998683-5 | Abdominal Pain, Duodenal Ulcer
Adverse event was reported on Sep 14, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 77 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), duodenal ulcer. During the same period patient was treated with PANCREAZE (Since Before Nexavar Administration) (View Pancreaze Review and Pancreaze Label ), MAGMITT (Since Before Nexavar Administration) (View Magmitt Review and Magmitt Label ), MUCOSTA (Since Before Nexavar Administration) (View Mucosta Review and Mucosta Label ), URSO 250 (Since Before Nexavar Administration) (View Urso 250 Review and Urso 250 Label ), GLIMICRON (Since Before Nexavar Administration) (View Glimicron Review and Glimicron Label ), LONGES (Since Before Nexavar Administration) (View Longes Review and Longes Label ), FERROMIA (Since Before Nexavar Administration) (View Ferromia Review and Ferromia Label ).

6998682-3 | Infection
on Sep 14, 2010 Female patient from SWEDEN , 58 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient had the following side effects: infection (What is infection?). Nexavar dosage: . During the same period patient was treated with ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ANASTROZOLE (View Anastrozole Review and Anastrozole Label ), FUROSEMID (View Furosemid Review and Furosemid Label ), LOSARTAN POTASSIUM (12.5) (View Losartan Potassium Review and Losartan Potassium Label ), MORFIN (View Morfin Review and Morfin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), TIOTROPIUMBROMID (View Tiotropiumbromid Review and Tiotropiumbromid Label ). Patient was hospitalized.

6998581-7 | Erythema Multiforme, Truncus Coeliacus Thrombosis
on Sep 15, 2010 Male patient from JAPAN , 70 years of age, weighting 105.8 lb, was diagnosed with hepatic neoplasm malignant, gastric ulcer and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: erythema multiforme, truncus coeliacus thrombosis. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with OMEPRAL (View Omepral Review and Omepral Label ), HALCION (Since Before Administration) (View Halcion Review and Halcion Label ), MAGMITT (View Magmitt Review and Magmitt Label ), LASIX (View Lasix Review and Lasix Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), GLAKAY (View Glakay Review and Glakay Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), LIVACT (View Livact Review and Livact Label ). Patient was hospitalized.

6998579-9 | Ascites, Decreased Appetite, Diarrhoea, Fatigue, Hepatic Neoplasm Malignant
Patient was taking Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, decreased appetite, diarrhoea, fatigue, hepatic neoplasm malignant on Sep 15, 2010 from JAPAN Additional patient health information: Male patient , 45 years of age, weighting 138.9 lb, was diagnosed with hepatic neoplasm malignant, gastritis prophylaxis and. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with GLAKAY (Unit Dose: 15 Mg) (View Glakay Review and Glakay Label ), BARACLUDE (Before Nexavar Administration) (View Baraclude Review and Baraclude Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), UREPEARL (View Urepearl Review and Urepearl Label ), IA COR (View Ia Cor Review and Ia Cor Label ), PARIET (View Pariet Review and Pariet Label ). Patient was hospitalized.

6998476-9 | Rhabdomyolysis
Adverse event was reported on Sep 15, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Total Daily Dose: 400 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 64 years of age, Patient had the following side effects: rhabdomyolysis.

6998475-7 | Hepatic Function Abnormal, Hyperkalaemia, Palmar-plantar Erythrodysaesthesia Syndrome
on Sep 15, 2010 Male patient from JAPAN , 69 years of age, weighting 121.3 lb, was diagnosed with renal cell carcinoma, hepatic function abnormal and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: hepatic function abnormal, hyperkalaemia, palmar-plantar erythrodysaesthesia syndrome. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with MINOPHAGEN C (View Minophagen C Review and Minophagen C Label ), MOBIC (View Mobic Review and Mobic Label ), MICARDIS (View Micardis Review and Micardis Label ), OXINORM (View Oxinorm Review and Oxinorm Label ). Patient was hospitalized.

6998474-5 | Stevens-johnson Syndrome
on Sep 15, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. Patient was hospitalized.

6998445-9 | Anaemia, Blood Amylase Increased, Blood Phosphorus Decreased, Colitis Ischaemic, Diarrhoea, Hypoalbuminaemia, Lipase Increased, Melaena, Pancytopenia
Patient was taking Nexavar (View Usage). Patient had the following side effects: anaemia, blood amylase increased, blood phosphorus decreased, colitis ischaemic, diarrhoea, hypoalbuminaemia, lipase increased, melaena, pancytopenia on Sep 10, 2010 from JAPAN Additional patient health information: Male patient , 73 years of age, weighting 119.0 lb, was diagnosed with hepatic neoplasm malignant and. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with FLUITRAN (Since Before Administration) (View Fluitran Review and Fluitran Label ), NORVASC (Since Before Administration) (View Norvasc Review and Norvasc Label ), TAKEPRON (Since Before Administration) (View Takepron Review and Takepron Label ), AMARYL (Since Before Administration) (View Amaryl Review and Amaryl Label ), ULCERLMIN (Since Before Administration) (View Ulcerlmin Review and Ulcerlmin Label ), GLAKAY (Since Before Administration) (View Glakay Review and Glakay Label ). Patient was hospitalized.

6998427-7 | Hepatic Encephalopathy
Adverse event was reported on Sep 14, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: GERMANY , 70 years of age, weighting 176.4 lb, After Nexavar was administered, patient had the following side effects: hepatic encephalopathy. During the same period patient was treated with RAMIPRIL (Total Daily Dose: 2.5 Mg) (View Ramipril Review and Ramipril Label ), PANTOPRAZOLE (Total Daily Dose: 40 Mg) (View Pantoprazole Review and Pantoprazole Label ), ALLOPURINOL (Total Daily Dose: 300 Mg) (View Allopurinol Review and Allopurinol Label ), SPIRONOLACTONE (Total Daily Dose: 50 Mg) (View Spironolactone Review and Spironolactone Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ). Patient was hospitalized.

6992510-8 | Balance Disorder, Disorientation, Oedema Peripheral, Palmar-plantar Erythrodysaesthesia Syndrome, Pruritus, Pyrexia, Tremor, Urticaria
on Jun 17, 2010 Female patient from FRANCE , 88 years of age, was diagnosed with hepatic neoplasm malignant, hypertension, osteoarthritis (What is osteoarthritis?), asthma (What is asthma?) and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, disorientation, oedema peripheral, palmar-plantar erythrodysaesthesia syndrome, pruritus, pyrexia, tremor, urticaria. Nexavar dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), IXPRIM (View Ixprim Review and Ixprim Label ), ACETAMINOPHEN W/ PROPOXYPHENE HCL (View Acetaminophen W/ Propoxyphene Hcl Review and Acetaminophen W/ Propoxyphene Hcl Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), BECOTIDE (View Becotide Review and Becotide Label ).

6992509-1 | Dyspnoea, Fatigue, Weight Decreased
on Sep 02, 2010 Female patient from BELGIUM , weighting 114.6 lb, was diagnosed with thyroid cancer (What is thyroid cancer?), cancer pain, hypertension and was treated with Nexavar (View Usage). Patient had the following side effects: dyspnoea, fatigue, weight decreased. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with NULYTELY (2 Sachets Per Day) (View Nulytely Review and Nulytely Label ), DURAGESIC 100 (50 Mcg/2 Days.) (View Duragesic-100 Review and Duragesic-100 Label ), MS DIRECT (View Ms Direct Review and Ms Direct Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), ELTHYRONE (View Elthyrone Review and Elthyrone Label ), CORDARONE (View Cordarone Review and Cordarone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6992505-4 | Aptyalism, Asthenia, Back Pain, Chest Pain, Dehydration, Disorientation, Dizziness, Dry Mouth, Glossodynia
Patient was taking Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: aptyalism, asthenia, back pain (What is back pain?), chest pain (What is chest pain?), dehydration, disorientation, dizziness (What is dizziness?), dry mouth, glossodynia on Sep 03, 2010 from BRAZIL Additional patient health information: Female patient , 53 years of age, weighting 121.3 lb, was diagnosed with hepatic neoplasm malignant, tumour pain, nausea (What is nausea?), depression (What is depression?), fibromyalgia and. Nexavar dosage: 2 Tablets / 2 X Day. During the same period patient was treated with TRAMAL RETARD (View Tramal Retard Review and Tramal Retard Label ), LYRICA (View Lyrica Review and Lyrica Label ), PLASIL (View Plasil Review and Plasil Label ), PURAN T4 (1 Tablet / Day) (View Puran T4 Review and Puran T4 Label ), TOTELLE (1 Tablet / Day) (View Totelle Review and Totelle Label ), ALPRAZOLAM (1 Tablet / Day) (View Alprazolam Review and Alprazolam Label ), CITALOPRAM HYDROBROMIDE (1 Tablet / Day) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized and became disabled.

6988507-4 | Blood Urea Increased, Cerebral Infarction, Decreased Appetite, Diarrhoea, Dizziness, Dysphonia, Fatigue, Haemoglobin Decreased, Malaise
Adverse event was reported on Sep 08, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Total Daily Dose: 400 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 80 years of age, weighting 127.9 lb, Patient experienced the following unwanted or unexpected effects: blood urea increased, cerebral infarction, decreased appetite, diarrhoea, dizziness (What is dizziness?), dysphonia, fatigue, haemoglobin decreased, malaise. During the same period patient was treated with NORVASC (Before Nexavar Administration) (View Norvasc Review and Norvasc Label ), TANATRIL (Before Nexavar Administration) (View Tanatril Review and Tanatril Label ), TENORMIN (Before Nexavar Administration) (View Tenormin Review and Tenormin Label ), MYONAL (Before Nexavar Administration) (View Myonal Review and Myonal Label ). Patient was hospitalized.

6988506-2 | Dehydration
on Sep 13, 2010 Male patient from SWEDEN , 72 years of age, weighting 174.2 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient had the following side effects: dehydration. Nexavar dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), COMBIVENT INHALATION (View Combivent Inhalation Review and Combivent Inhalation Label ), FUROSEMID (View Furosemid Review and Furosemid Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NORVASC (View Norvasc Review and Norvasc Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZESTRIL (View Zestril Review and Zestril Label ). Patient was hospitalized.

6988504-9 | Open Wound
on Sep 09, 2010 Male patient from JAPAN , 67 years of age, weighting 127.9 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: open wound. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with KERATINAMIN (View Keratinamin Review and Keratinamin Label ), LASIX (View Lasix Review and Lasix Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), OMEPRAL (View Omepral Review and Omepral Label ). Patient was hospitalized.

6987265-7 | Dermatitis Exfoliative, Skin Necrosis
Patient was taking Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, skin necrosis on Sep 08, 2010 from CZECH REPUBLIC Additional patient health information: Male patient , 69 years of age, was diagnosed with renal cancer and. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with ROFERON A (View Roferon-a Review and Roferon-a Label ), TRALGIT (Total Daily Dose: 20 Gtt) (View Tralgit Review and Tralgit Label ), BONDRONAT (One Tablet A Day) (View Bondronat Review and Bondronat Label ).

6987262-1 | Hepatic Function Abnormal, Hepatic Neoplasm Malignant, Jaundice
Adverse event was reported on Sep 13, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 77 years of age, weighting 132.3 lb, Patient had the following side effects: hepatic function abnormal, hepatic neoplasm malignant, jaundice (What is jaundice?). During the same period patient was treated with PROTECADIN (View Protecadin Review and Protecadin Label ), BEZATOL SR (View Bezatol Sr Review and Bezatol Sr Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), HALCION (View Halcion Review and Halcion Label ), JUVELA N (View Juvela N Review and Juvela N Label ), LECICARBON (View Lecicarbon Review and Lecicarbon Label ), HYPEN (View Hypen Review and Hypen Label ). Patient was hospitalized.

6987261-X | Abdominal Distension, Abdominal Pain, Hepatic Failure, Liver Carcinoma Ruptured, Rash
on Sep 13, 2010 Female patient from JAPAN , 86 years of age, weighting 103.6 lb, was diagnosed with hepatic neoplasm malignant, prophylaxis, abdominal distension, reflux oesophagitis and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), hepatic failure, liver carcinoma ruptured, rash (What is rash?). Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with UREPEARL L (View Urepearl L Review and Urepearl L Label ), LIVACT (View Livact Review and Livact Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), GASCON (View Gascon Review and Gascon Label ), GLYCYRON (View Glycyron Review and Glycyron Label ), PARIET (View Pariet Review and Pariet Label ), RIKKUNSHITO, NOS (View Rikkunshito, Nos Review and Rikkunshito, Nos Label ). Patient was hospitalized.

6987260-8 | Alopecia, Diarrhoea, Hepatic Function Abnormal, Hypertension, Interstitial Lung Disease, Palmar-plantar Erythrodysaesthesia Syndrome, Renal Impairment
on Sep 13, 2010 Male patient from JAPAN , 76 years of age, weighting 141.1 lb, was diagnosed with hepatic neoplasm malignant, prophylaxis and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, diarrhoea, hepatic function abnormal, hypertension, interstitial lung disease, palmar-plantar erythrodysaesthesia syndrome, renal impairment. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with GASTER D (View Gaster D Review and Gaster D Label ), GASLON N_OD (View Gaslon N_od Review and Gaslon N_od Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), MAGMITT (View Magmitt Review and Magmitt Label ). Patient was hospitalized.

6987258-X | Hepatic Function Abnormal, Platelet Count Decreased
Patient was taking Nexavar (View Usage). Patient had the following side effects: hepatic function abnormal, platelet count decreased on Sep 09, 2010 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with hepatic neoplasm malignant and. Nexavar dosage: Total Daily Dose: 400 Mg Unit Dose: 200 Mg.

6987257-8 | Palmar-plantar Erythrodysaesthesia Syndrome, Pancytopenia, Platelet Count Decreased
Adverse event was reported on Sep 08, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 42 years of age, After Nexavar was administered, patient had the following side effects: palmar-plantar erythrodysaesthesia syndrome, pancytopenia, platelet count decreased.

6987256-6 | Varicose Vein Ruptured
on Sep 13, 2010 Male patient from JAPAN , 55 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: varicose vein ruptured. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. Patient was hospitalized.

6987255-4 | Decreased Appetite
on Sep 13, 2010 Female patient from SWEDEN , 72 years of age, weighting 119.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient had the following side effects: decreased appetite. Nexavar dosage: . During the same period patient was treated with SIMVASTATIN (Vb) (View Simvastatin Review and Simvastatin Label ), KALE (View Kale Review and Kale Label ). Patient was hospitalized.

6985284-8 | Dry Skin, Lung Neoplasm, Lymphadenopathy, Skin Disorder
Patient was taking Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: dry skin, lung neoplasm, lymphadenopathy, skin disorder on Sep 08, 2010 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 200.6 lb, was diagnosed with renal cell carcinoma and. Nexavar dosage: Unit Dose: 200 Mg.

6985280-0 | Cancer Pain, Cholangitis, Constipation, Dysuria, Hepatic Encephalopathy, Hepatic Neoplasm Malignant, Liver Disorder, Pancreatitis, Rash
Adverse event was reported on Sep 08, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant, hyperlipidaemia, hypertension, hepatitis (What is hepatitis?), productive cough, prophylaxis and. Location: JAPAN , 71 years of age, weighting 167.6 lb, Patient experienced the following unwanted or unexpected effects: cancer pain, cholangitis, constipation (What is constipation?), dysuria, hepatic encephalopathy, hepatic neoplasm malignant, liver disorder, pancreatitis, rash (What is rash?). During the same period patient was treated with LETRAC (Since Before Administration) (View Letrac Review and Letrac Label ), PRAVASTATIN SODIUM (Since Before Administration) (View Pravastatin Sodium Review and Pravastatin Sodium Label ), NU LOTAN (Since Before Administration) (View Nu-lotan Review and Nu-lotan Label ), CALSLOT (Since Before Administration) (View Calslot Review and Calslot Label ), URSO 250 (Since Before Administration) (View Urso 250 Review and Urso 250 Label ), MUCODYNE (Since Before Administration) (View Mucodyne Review and Mucodyne Label ), PYDOXAL (View Pydoxal Review and Pydoxal Label ), HIRUDOID (View Hirudoid Review and Hirudoid Label ).

6985278-2 | Blood Amylase Increased, Hepatic Function Abnormal, Hypertension, Lipase Increased, Palmar-plantar Erythrodysaesthesia Syndrome
on Sep 14, 2010 Male patient from JAPAN , 67 years of age, weighting 121.3 lb, was diagnosed with renal cell carcinoma and was treated with Nexavar (View Usage). Patient had the following side effects: blood amylase increased, hepatic function abnormal, hypertension, lipase increased, palmar-plantar erythrodysaesthesia syndrome. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. Patient was hospitalized.

6984712-1 | Disseminated Intravascular Coagulation, Erythema Multiforme, Oropharyngeal Pain
on Sep 10, 2010 Male patient from JAPAN , 83 years of age, weighting 116.8 lb, was diagnosed with hepatic neoplasm malignant, hepatitis c (What is hepatitis c?), reflux oesophagitis, constipation (What is constipation?) and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: disseminated intravascular coagulation, erythema multiforme, oropharyngeal pain. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with URSO 250 (Unit Dose: 100 Mg) (View Urso 250 Review and Urso 250 Label ), PROHEPARUM (View Proheparum Review and Proheparum Label ), TAKEPRON (Unit Dose: 15 Mg) (View Takepron Review and Takepron Label ), PANTOSIN (Unit Dose 200mg/g) (View Pantosin Review and Pantosin Label ).

6984711-X | Nephrotic Syndrome, Pyrexia
Patient was taking Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: nephrotic syndrome, pyrexia on Sep 10, 2010 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with renal cell carcinoma and. Nexavar dosage: Unit Dose: 200 Mg. Patient was hospitalized.

6984710-8 | Blood Creatine Phosphokinase Increased, Palmar-plantar Erythrodysaesthesia Syndrome
Adverse event was reported on Sep 09, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Total Daily Dose: 400 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 59 years of age, weighting 180.8 lb, Patient had the following side effects: blood creatine phosphokinase increased, palmar-plantar erythrodysaesthesia syndrome. During the same period patient was treated with HERLAT L (Unit Dose: 20 Mg) (View Herlat L Review and Herlat L Label ), PARIET (Unit Dose: 10 Mg) (View Pariet Review and Pariet Label ), FOSAMAC 35MG (Unit Dose: 35 Mg) (View Fosamac 35mg Review and Fosamac 35mg Label ), PROMAC (Unit Dose: 75 Mg) (View Promac Review and Promac Label ), PREDONINE (View Predonine Review and Predonine Label ), HUMALOG MIX (View Humalog Mix Review and Humalog Mix Label ), LIPITOR (Unit Dose: 10 Mg) (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6984709-1 | Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Hepatic Function Abnormal, Stevens-johnson Syndrome
on Sep 10, 2010 Male patient from JAPAN , 72 years of age, weighting 88.18 lb, was diagnosed with hepatic neoplasm malignant, hepatitis b (What is hepatitis b?) and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: aspartate aminotransferase increased, blood bilirubin increased, hepatic function abnormal, stevens-johnson syndrome. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with ENTECAVIR HYDRATE (View Entecavir Hydrate Review and Entecavir Hydrate Label ). Patient was hospitalized.

6984707-8 | Hepatic Encephalopathy
on Sep 02, 2010 Male patient from GERMANY , 70 years of age, weighting 176.4 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic encephalopathy. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with RAMIPRIL (Total Daily Dose: 2.5 Mg) (View Ramipril Review and Ramipril Label ), PANTOPRAZOLE (Total Daily Dose: 40 Mg) (View Pantoprazole Review and Pantoprazole Label ), ALLOPURINOL (Total Daily Dose: 300 Mg) (View Allopurinol Review and Allopurinol Label ), SPIRONOLACTONE (Total Daily Dose: 50 Mg) (View Spironolactone Review and Spironolactone Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ). Patient was hospitalized.

6984706-6 | Decreased Appetite, Dehydration, Fatigue, Hepatic Neoplasm Malignant, Weight Decreased
Patient was taking Nexavar (View Usage). Patient had the following side effects: decreased appetite, dehydration, fatigue, hepatic neoplasm malignant, weight decreased on Sep 13, 2010 from SWEDEN Additional patient health information: Female patient , 64 years of age, weighting 108.0 lb, was diagnosed with hepatic neoplasm malignant, nausea (What is nausea?), pain (What is pain?), pruritus and. Nexavar dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ), OXYCODONE HCL (As Used: 5 Mg) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), TAVEGYL (View Tavegyl Review and Tavegyl Label ), ZOPIKION (View Zopikion Review and Zopikion Label ). Patient was hospitalized.